Pharmacological strategies for reduction of lipid availability

Annals of the New York Academy of Sciences

Volumn 827, Issue , 1997, Pages 231-245

  Foley, James E ^a   Anderson, Robert C ^a   Bell, Philip A ^a   Burkey, Bryan F ^a   Deems, Rhonda O ^a   De Souza, Christopher ^a   Dunning, Beth E ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6 N CYCLOHEXYL 2' O METHYLADENOSINE; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE CELL; ANIMAL CELL; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOLYSIS; MOUSE; NONHUMAN; RAT;

ANIMALIA;

EID: 0030698357     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb51838.x     Document Type: Conference Paper

References (28)

1. REAVEN, G. M. 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
2. RANDLE, P. J., C. N. HALES, P. B. GARLAND &E. A. NEWSHOLME. 1963. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785-789.
3. FELBER, J. P., E. HAESLER &E. JEQUIER. 1993. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:1221-1229.
4. ZHOU, Y. P. &V. E. GRILL. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93: 870-876.
5. REBERIN, K., G. M. STEIL, L. GETTY &R. N. BERGMAN. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045.
6. BODEN, G., X. CHEN, J. Ruiz, J. V. WHITE &L. ROSSETTI. 1994. Mechanisms of fatty acidinduced inhibition of glucose uptake. J. Clin. Invest. 93: 2438-2446.
7. FOLEY, J. E. I992. Rationale and application of fatty acid oxidation inhibitors in the treatment of diabetes mellitus. Diabetes Care 15: 773-784.
8. FOLEY, J. E. &R. C. ANDERSON. 1996. Fatty acid oxidation inhibitors. In Diabetes Mellitus: A Fundamental Clinical Text, p. 668-674. Lippincott-Raven. Philadelphia/New York.
9. ANDREWS, J., A. KASHIWAGI, M. A. VERSO, B. VASQUEZ, B. V. HOWARD &J. E. FOLEY. 1984. Effects of four-day fest on triglyceride mobilization in human adipocytes. Int. J. Obes. 8:355-363.
10. BOGARDUS, C., S. LlLLIOJA, D. MOTT, G. M. REAVEN, A. KASHIWAGI &J. E. FOLEY. 1984. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J. Clin. Invest. 73: 800-805.
11. PAOLISSO, G., P. A. TATARANNI, J. E. FOLEY, C. BOGARDUS, B. V. HOWARD &E. RAVUSSIN. 1995. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38: 1213-1217.
12. LILUOJA, S., J. E. FOLEY, C. BOGARDUS, D. MOTT &B. V. HOWARD. 1986. Free fatty acid metabolism and obesity in man: in vivo and in vitro comparisons. Metabolism 35: 505-514.
13. HOWARD, B. V., C. BOGARDUS, E. RAVUSSIN, J. E. FOLEY, S. LILUOJA, D. M. MOTT, P. H. BENNETT &W. C. KNOWLER. 1991. Studies of the etiology of obesity in Pima Indians. Am. J. Clin. Nutr. 53: 1577S-1585S.
14. KASHIWAGI, A., D. Morr, C. BOGARDUS, S. LILLIOJA, G. M. REAVEN &J. E. FOLEY. 1985. The effects of short-term overfeeding on adipocyte metabolism in Pima Indians. Metabolism 34: 364-370.
15. ABBOTT, G. H. &J. E. FOLEY. 1987. Comparison of body composition, adipocyte size, and glucose and insulin concentrations in Pima Indian and Caucasian children. Metabolism 36: 576-579.
16. MOTT, D. M., S. LILUOJA &C. BOGARDUS. 1986. Overnutrition induced decrease in insulin action for glucose storage in mv and in vitro in man. Metabolism 35: 160-165.
17. ZHANG, Y., R. PROENCA, M. MAFFEL, M. BARONE, L. LEOPOLD &J. M. FRIEDMAN. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
18. KELLEY, D., M. MOKAN &T. VENEMAN. 1994. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43: 1549-1557.
19. WHITCOMB, R. W. &A. R. SALTIEL. 1995. Thiazolidinediones. Exp. Opin. Invest. Drugs 4: 1299-1309.
20. LEHMANN, J. M., L. B. MOORE, T. A. SMITH-OLIVER, W. O. WILKISON, T. M. WILLSON & S. A. KLIEWER. 1995. An antidiabetic thiazolidinedione is a high-affinity ligand for the nuclear peroxisome proliferator-activated receptor y (PPARy). J. Biol. Chem. 270:12953-12956.
21. ZHANG, B., M. P. GRAZIANO,T. W. DOEBBER, M. D. LEIBOWITZ, S. WHITE-CARRINGTON, D. M. SZALKOWSKI, P. J. HEY, M. Wu, C. A. CULLJNAN, P. BAILEY, B. LOLLMANN, R. FREDERICH, J. S. FUER, C. D. STRADER &R. G. SMITH. 1996. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271: 9455-9459.
22. IWAMOTO, Y., K. KOSAKA, T. KUZUYA, Y. AKANUMA, Y. SHIGETA &T. KANEKO. 1996. Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19: 151-156.
23. KALLEN, C. B. &M. A. LAZAR. 1996. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U.S.A. 93: 5793-5796.
24. STILES, G. L. 1992. Adenosine receptors. J. Biol. Chem. 267: 6451-6454.
25. HONNOR, R. C., G. S. DHILLON &C. LONDOS. 1985. cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J. Biol. Chem. 260: 15130-15138.
26. KURODA, M., R. C. HONNOR, S. W. CUSHMAN, C. LONDOS &I. W. SIMPSON. 1987. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. J. Biol. Chem. 262:245-253.
27. WAGNER, H., M. MILAVEC-KRIZMAN, F. GADIENT, K. MENNINGER, P. SCHOEFFTER, C. TAPPARELLI, J. P. PFANNKUCHE &J. R. FOZARD. 1995. General pharmacological properties of SDZ WAG 994, a potent, selective, and orally active adenosine Ai receptor agonist. Drug Dev. Res. 34: 276-288.
28. FROST, S. C. &M. D. LANE. 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260: 2646-2652.